Specifically, our analysis on the lists of DC genes confirms the results provided by DE analyses in [17] by hinting to a role for immune processes in MS and as response to IFN-β treatment (Reactome Immune System p=10-27 in GSE41846, p=10-9 in GSE41847, p=10-15 in GSE16214, p=10-6 in GSE41848, p=10-5 in GSE41849). This evidence concerns the gene IFNB1 and myeloid sarcoma.